Literature DB >> 7935852

H3 receptor-mediated inhibition of noradrenaline release: an investigation into the involvement of Ca2+ and K+ ions, G protein and adenylate cyclase.

E Schlicker1, M Kathmann, M Detzner, H J Exner, M Göthert.   

Abstract

The present study was aimed at the identification of mechanisms following the activation of histamine H3 receptors. Mouse brain cortex slices preincubated with 3H-noradrenaline were superfused and the (H3 receptor-mediated) effect of histamine on the electrically evoked tritium overflow was studied under a variety of conditions. The extent of inhibition produced by histamine was inversely related to the frequency of stimulation used to evoke tritium overflow and to the Ca2+ concentration in the superfusion medium. An activator (levcromakalim) and blocker (glibenclamide) of ATP-dependent K+ channels did not affect the electrically evoked tritium overflow and its inhibition by histamine. A blocker of voltage-sensitive K+ channels, tetraethylammonium (TEA), increased the evoked overflow and attenuated the inhibitory effect of histamine. TEA also reduced the inhibitory effect of noradrenaline and prostaglandin E2 on the evoked overflow. When the facilitatory effect of TEA on the evoked overflow was compensated for by reducing the Ca2+ concentration in the superfusion medium, TEA did no longer attenuate the effect of histamine. Exposure of the slices to the SH group-alkylating agent N-ethylmaleimide increased the evoked overflow and attenuated the inhibitory effect of histamine; both effects were counteracted by the SH group-protecting agent dithiothreitol, which, by itself, did not affect the evoked overflow and its inhibition by histamine. Mouse brain cortex membranes were used to study the effect of the H3 receptor agonist R-(-)-alpha-methylhistamine on the basal cAMP accumulation and on the accumulation stimulated by forskolin or noradrenaline.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7935852     DOI: 10.1007/bf00180008

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  31 in total

1.  Histamine-induced increases in cyclic AMP levels in bovine adrenal medullary cells.

Authors:  P D Marley; K A Thomson; K Jachno; M J Johnston
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

Review 2.  Modulation of neurotransmitter release by presynaptic autoreceptors.

Authors:  K Starke; M Göthert; H Kilbinger
Journal:  Physiol Rev       Date:  1989-07       Impact factor: 37.312

Review 3.  Mechanisms and components involved in adenylate cyclase inhibition by hormones.

Authors:  K H Jakobs; K Aktories; G Schultz
Journal:  Adv Cyclic Nucleotide Protein Phosphorylation Res       Date:  1984

Review 4.  Regulatory proteins in presynaptic function.

Authors:  G Hertting; S Wurster; C Allgaier
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

5.  Histamine H3 receptor binding sites in rat brain membranes: modulations by guanine nucleotides and divalent cations.

Authors:  J M Arrang; J Roy; J L Morgat; W Schunack; J C Schwartz
Journal:  Eur J Pharmacol       Date:  1990-04-25       Impact factor: 4.432

6.  Effects of histamine H3-receptor ligands on various biochemical indices of histaminergic neuron activity in rat brain.

Authors:  M Garbarg; M D Tuong; C Gros; J C Schwartz
Journal:  Eur J Pharmacol       Date:  1989-05-02       Impact factor: 4.432

7.  Histamine H3A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex.

Authors:  E Schlicker; A Behling; G Lümmen; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

8.  Purification of a histamine H3 receptor negatively coupled to phosphoinositide turnover in the human gastric cell line HGT1.

Authors:  Y Cherifi; C Pigeon; M Le Romancer; A Bado; F Reyl-Desmars; M J Lewin
Journal:  J Biol Chem       Date:  1992-12-15       Impact factor: 5.157

9.  Differential effects of diazoxide, cromakalim and pinacidil on adrenergic neurotransmission and 86Rb+ efflux in rat brain cortical slices.

Authors:  Y Takata; F Shimada; H Kato
Journal:  J Pharmacol Exp Ther       Date:  1992-12       Impact factor: 4.030

10.  Nordimaprit, homodimaprit, clobenpropit and imetit: affinities for H3 binding sites and potencies in a functional H3 receptor model.

Authors:  M Kathmann; E Schlicker; M Detzner; H Timmerman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

View more
  13 in total

1.  Regulation of norepinephrine release from isolated bovine irides by histamine.

Authors:  Kaustubh H Kulkarni; Catherine A Opere; Angela M LeDay; Mohd A Shara; Sunny E Ohia
Journal:  Neurochem Res       Date:  2006-06-29       Impact factor: 3.996

2.  The moderate affinity of clozapine at H3 receptors is not shared by its two major metabolites and by structurally related and unrelated atypical neuroleptics.

Authors:  E Schlicker; I Marr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

3.  Interaction Between Brain Histamine and Serotonin, Norepinephrine, and Dopamine Systems: In Vivo Microdialysis and Electrophysiology Study.

Authors:  Gunnar Flik; Joost H A Folgering; Thomas I H F Cremers; Ben H C Westerink; Eliyahu Dremencov
Journal:  J Mol Neurosci       Date:  2015-03-29       Impact factor: 3.444

4.  Histamine H(3) receptors mediate inhibition of noradrenaline release from intestinal sympathetic nerves.

Authors:  C Blandizzi; M Tognetti; R Colucci; M Del Tacca
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 5.  An update on histamine H3 receptors and gastrointestinal functions.

Authors:  G Bertaccini; G Coruzzi
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

6.  Histaminergic modulation of GABAergic transmission in rat ventromedial hypothalamic neurones.

Authors:  I S Jang; J S Rhee; T Watanabe; N Akaike; N Akaike
Journal:  J Physiol       Date:  2001-08-01       Impact factor: 5.182

Review 7.  International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.

Authors:  Pertti Panula; Paul L Chazot; Marlon Cowart; Ralf Gutzmer; Rob Leurs; Wai L S Liu; Holger Stark; Robin L Thurmond; Helmut L Haas
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

8.  Anxiolytic-like profiles of histamine H3 receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic.

Authors:  Fumikazu Yokoyama; Miki Yamauchi; Masayo Oyama; Kunihiro Okuma; Kaname Onozawa; Takako Nagayama; Rie Shinei; Makoto Ishikawa; Yasuo Sato; Nobukazu Kakui
Journal:  Psychopharmacology (Berl)       Date:  2009-04-09       Impact factor: 4.530

9.  Prostanoid receptors of the EP3 subtype mediate the inhibitory effect of prostaglandin E2 on noradrenaline release in the mouse brain cortex.

Authors:  H J Exner; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

10.  Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.

Authors:  R Leurs; M T Tulp; W M Menge; M J Adolfs; O P Zuiderveld; H Timmerman
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.